Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Lipid pathway deregulation in advanced prostate cancer.

Galbraith L, Leung HY, Ahmad I.

Pharmacol Res. 2018 May;131:177-184. doi: 10.1016/j.phrs.2018.02.022. Epub 2018 Feb 18. Review.

PMID:
29466694
2.

Step it up! Using the good behavior game to increase physical activity with elementary school students at recess.

Galbraith LA, Normand MP.

J Appl Behav Anal. 2017 Oct;50(4):856-860. doi: 10.1002/jaba.402. Epub 2017 Aug 12.

PMID:
28801941
3.

Chronic disease management interventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis.

Galbraith L, Jacobs C, Hemmelgarn BR, Donald M, Manns BJ, Jun M.

Nephrol Dial Transplant. 2018 Jan 1;33(1):112-121. doi: 10.1093/ndt/gfw359.

PMID:
28096482
4.

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.

Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno AL, Le Toumelin-Braizat G, Chanrion M, Kelly GL, Gong JN, Moujalled DM, Bruno A, Csekei M, Paczal A, Szabo ZB, Sipos S, Radics G, Proszenyak A, Balint B, Ondi L, Blasko G, Robertson A, Surgenor A, Dokurno P, Chen I, Matassova N, Smith J, Pedder C, Graham C, Studeny A, Lysiak-Auvity G, Girard AM, Gravé F, Segal D, Riffkin CD, Pomilio G, Galbraith LC, Aubrey BJ, Brennan MS, Herold MJ, Chang C, Guasconi G, Cauquil N, Melchiore F, Guigal-Stephan N, Lockhart B, Colland F, Hickman JA, Roberts AW, Huang DC, Wei AH, Strasser A, Lessene G, Geneste O.

Nature. 2016 Oct 27;538(7626):477-482. doi: 10.1038/nature19830. Epub 2016 Oct 19.

PMID:
27760111
5.

The association between individual counselling and health behaviour change: the See Kidney Disease (SeeKD) targeted screening programme for chronic kidney disease.

Galbraith L, Hemmelgarn B, Manns B, Samuel S, Kappel J, Valk N, Ronksley P.

Can J Kidney Health Dis. 2016 Jul 20;3:35. doi: 10.1186/s40697-016-0127-4. eCollection 2016.

6.

Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.

Ahmad I, Mui E, Galbraith L, Patel R, Tan EH, Salji M, Rust AG, Repiscak P, Hedley A, Markert E, Loveridge C, van der Weyden L, Edwards J, Sansom OJ, Adams DJ, Leung HY.

Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8290-5. doi: 10.1073/pnas.1601571113. Epub 2016 Jun 29.

7.

The See Kidney Disease Targeted Screening Program for CKD.

Galbraith LE, Ronksley PE, Barnieh LJ, Kappel J, Manns BJ, Samuel SM, Jun M, Weaver R, Valk N, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):964-72. doi: 10.2215/CJN.11961115. Epub 2016 May 19.

8.

Defining functional classes of Barth syndrome mutation in humans.

Lu YW, Galbraith L, Herndon JD, Lu YL, Pras-Raves M, Vervaart M, Van Kampen A, Luyf A, Koehler CM, McCaffery JM, Gottlieb E, Vaz FM, Claypool SM.

Hum Mol Genet. 2016 May 1;25(9):1754-70. doi: 10.1093/hmg/ddw046. Epub 2016 Feb 16.

9.

Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells.

Baenke F, Chaneton B, Smith M, Van Den Broek N, Hogan K, Tang H, Viros A, Martin M, Galbraith L, Girotti MR, Dhomen N, Gottlieb E, Marais R.

Mol Oncol. 2016 Jan;10(1):73-84. doi: 10.1016/j.molonc.2015.08.003. Epub 2015 Aug 20.

10.

Preliminary results for salt aerosol production intended for marine cloud brightening, using effervescent spray atomization.

Cooper G, Foster J, Galbraith L, Jain S, Neukermans A, Ormond B.

Philos Trans A Math Phys Eng Sci. 2014 Dec 28;372(2031). pii: 20140055. doi: 10.1098/rsta.2014.0055.

11.

The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial.

Galbraith L, Manns B, Hemmelgarn B, Walsh M.

Can J Kidney Health Dis. 2014 Nov 28;1:30. doi: 10.1186/s40697-014-0030-9. eCollection 2014.

12.

Marine cloud brightening.

Latham J, Bower K, Choularton T, Coe H, Connolly P, Cooper G, Craft T, Foster J, Gadian A, Galbraith L, Iacovides H, Johnston D, Launder B, Leslie B, Meyer J, Neukermans A, Ormond B, Parkes B, Rasch P, Rush J, Salter S, Stevenson T, Wang H, Wang Q, Wood R.

Philos Trans A Math Phys Eng Sci. 2012 Sep 13;370(1974):4217-62. doi: 10.1098/rsta.2012.0086.

13.

The music of lipids: how lipid composition orchestrates cellular behaviour.

Schug ZT, Frezza C, Galbraith LC, Gottlieb E.

Acta Oncol. 2012 Mar;51(3):301-10. doi: 10.3109/0284186X.2011.643823. Epub 2012 Jan 30.

PMID:
22283492
14.

Profiling health in the UK and Ireland.

Hill A, Balanda K, Galbraith L, Greenacre J, Sinclair D.

Public Health. 2010 May;124(5):253-8. doi: 10.1016/j.puhe.2010.03.008. Epub 2010 May 11.

PMID:
20462616
15.

Smoking prevalence and smoking cessation services for pregnant women in Scotland.

Tappin DM, MacAskill S, Bauld L, Eadie D, Shipton D, Galbraith L.

Subst Abuse Treat Prev Policy. 2010 Jan 21;5:1. doi: 10.1186/1747-597X-5-1.

16.

Phenotypic suppression of the Drosophila mitochondrial disease-like mutant tko(25t) by duplication of the mutant gene in its natural chromosomal context.

Kemppainen E, Fernández-Ayala DJ, Galbraith LC, O'Dell KM, Jacobs HT.

Mitochondrion. 2009 Sep;9(5):353-63. doi: 10.1016/j.mito.2009.07.002. Epub 2009 Jul 17.

PMID:
19616644
17.
18.

Caregivers' satisfaction with hospice care in the last 24 hours of life.

Casarett DJ, Hirschman KB, Crowley R, Galbraith LD, Leo M.

Am J Hosp Palliat Care. 2003 May-Jun;20(3):205-10.

PMID:
12785042
19.

Lipid composition and taxonomy of [Pseudomonas] echinoides: transfer to the genus Sphingomonas.

Rowe NJ, Tunstall J, Galbraith L, Wilkinson SG.

Microbiology. 2000 Nov;146 ( Pt 11):3007-12.

PMID:
11065379
20.

Structures of the O21 and O25 antigens of Stenotrophomonas maltophilia.

Galbraith L, Wilkinson SG.

Carbohydr Res. 2000 Jan 12;323(1-4):98-102.

PMID:
10782291
21.

Structure of the O-specific polysaccharide for Acinetobacter baumannii serogroup O1.

Galbraith L, Sharples JL, Wilkinson SG.

Carbohydr Res. 1999 Jun 30;319(1-4):204-8.

PMID:
10520267
23.
24.

Structure of the O-specific polysaccharide from Burkholderia pickettii strain NCTC 11149.

Galbraith L, George R, Wyklicky J, Wilkinson SG.

Carbohydr Res. 1996 Mar 18;282(2):263-9.

PMID:
8901090
25.
26.

Structural and serological studies of lipopolysaccharides from proposed new serotypes (O25 and O26) of Serratia marcescens.

Aucken HM, Merkouroglou M, Miller AW, Galbraith L, Wilkinson SG.

FEMS Microbiol Lett. 1995 Aug 1;130(2-3):267-72.

PMID:
7544311
27.

Structure of a surface polysaccharide from Acinetobacter baumannii strain 214.

Haseley SR, Galbraith L, Wilkinson SG.

Carbohydr Res. 1994 May 20;258:199-206.

PMID:
8039176
28.

Structure of the O19 antigen of Xanthomonas maltophilia.

Winn AM, Galbraith L, Temple GS, Wilkinson SG.

Carbohydr Res. 1993 Sep 2;247:249-54.

PMID:
7693347
29.

Behavioural treatment for sleep disturbance.

Galbraith L, Hewitt KE.

Health Visit. 1993 May;66(5):169-71. No abstract available.

PMID:
8514512
30.

An overnight retreat to facilitate coping with stress.

Galbraith LK, Kaiser S, Mahoney D, Moore-Harris L, Polman L, Ross L, Vaughn G, Willenbrink D.

Pediatr Nurs. 1992 Jul-Aug;18(4):372-4.

PMID:
1518675
31.

Human immunodeficiency resulting from a maturational arrest of germinal center B cells.

Braun J, Galbraith L, Valles-Ayoub Y, Saxon A.

Immunol Lett. 1992 Mar;32(1):99. No abstract available.

PMID:
1500089
32.

Treatment for alteration in oral mucosa related to chemotherapy.

Galbraith LK, Bailey D, Kelly L, Rehn K, Spear S, Steinle C, Vaughn G, Wehage S.

Pediatr Nurs. 1991 May-Jun;17(3):233-6.

PMID:
2062581
33.

Human immunodeficiency resulting from a maturational arrest of germinal center B cells.

Braun J, Galbraith L, Valles-Ayoub Y, Saxon A.

Immunol Lett. 1991 Mar;27(3):205-8. Erratum in: Immunol Lett. 1992 Mar;32(1):99.

PMID:
1905679
35.

Staphylococcal slime: a cautionary tale.

Drewry DT, Galbraith L, Wilkinson BJ, Wilkinson SG.

J Clin Microbiol. 1990 Jun;28(6):1292-6.

36.
37.

Re-evaluation of the diagnostic utility of serum total creatine kinase and creatine kinase-2 in myocardial infarction.

Leung FY, Galbraith LV, Jablonsky G, Henderson AR.

Clin Chem. 1989 Jul;35(7):1435-40. Erratum in: Clin Chem 1989 Nov;35(11):2257. Clin Chem 1990 Aug;36(8 Pt 1):1530.

38.

Structure of the O-specific polysaccharide from Enterobacter cloacae strain N.C.T.C. 11579 (serogroup O10).

Moule AL, Kuhl PM, Galbraith L, Wilkinson SG.

Carbohydr Res. 1989 Mar 15;186(2):287-93.

PMID:
2472202
39.

Failure to flourish: indications for mentoring.

Galbraith LS, Brueggemeyer AE, Manweiler DL.

Pediatr Nurs. 1988 Sep-Oct;14(5):405-8. No abstract available.

PMID:
3186311
40.

Postnatal classes on prevention of sleeplessness in young children.

Hewitt K, Galbraith L.

Child Care Health Dev. 1987 Nov-Dec;13(6):415-20.

PMID:
3440320
41.

Nucleotide sequence analysis of murine 21-hydroxylase genes: mutations affecting gene expression.

Chaplin DD, Galbraith LJ, Seidman JG, White PC, Parker KL.

Proc Natl Acad Sci U S A. 1986 Dec;83(24):9601-5.

42.

Structural alterations in the envelope of a gentamicin-resistant rough mutant of Pseudomonas aeruginosa.

Galbraith L, Wilkinson SG, Legakis NJ, Genimata V, Katsorchis TA, Rietschel ET.

Ann Microbiol (Paris). 1984 Sep-Oct;135B(2):121-36.

PMID:
6439097
44.

Polar lipids of Pseudomonas vesicularis. Presence of a heptosyldiacylglycerol.

Wilkinson SG, Galbraith L.

Biochim Biophys Acta. 1979 Nov 21;575(2):244-54.

PMID:
508784
45.

Cell walls, lipids, and lipopolysaccharides of Pseudomonas species.

Wilkinson SG, Galbraith L, Lightfoot GA.

Eur J Biochem. 1973 Feb 15;33(1):158-74. No abstract available.

46.

Intra-uterine rupture of Meckel's diverticulum with atresia of the ileum.

KING MK, WOOD HW, GALBRAITH LM, MURPHY WF.

Va Med Mon (1918). 1955 Dec;82(12):540-3. No abstract available.

PMID:
13274731

Supplemental Content

Loading ...
Support Center